Rosmarinic acid inhibits migration, invasion, and p38/AP-1 signaling via miR-1225-5p in colorectal cancer cells

被引:31
作者
Yang, Kaiyan [1 ]
Shen, Zhaolong [1 ]
Zou, Yueyi [1 ]
Gao, Kai [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Gastrointestinal Surg, Changsha 410013, Hunan, Peoples R China
关键词
miR-1225-5p; HT-29; cells; Nrf2; p38; Rosmarinic acid; IL17RA; P38; MAPK; MICRORNAS; GLIOBLASTOMA; PROGRESSION; ACTIVATION; STRESS; KEAP1;
D O I
10.1080/10799893.2020.1808674
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elucidating the molecular mechanism of the migration and invasion is critical for identifying novel therapeutic targets and may significantly improve the prognosis of colorectal cancer. Emerging evidence suggests an involvement of dysregulated microRNAs in the process of tumorigenesis. Here, we show that miR-1225-5p prevents migration and invasion of colorectal cancer cells. Overexpression of miR-1225-5p significantly decreases the expression of Matrix Metalloproteases (MMPs)-1, 3, and 9. Knockdown of miR-1225-5p elevates ROS levelviaregulating Keap1/Nrf2 pathway. Furthermore, miR-1225-5p attenuates IL-17A-induced p38/AP-1-signaling pathway by suppressing IL-17RA expression. We also examined the biological effects of Rosmarinic acid (RA) on metastatic colorectal cancer cells. RA inhibited EMTviathe p38/AP-1 signaling, and miR-1225-5p is essential for RA-mediated anti-metastatic effects.
引用
收藏
页码:284 / 293
页数:10
相关论文
共 42 条
  • [1] Rosmarinic Acid - Pharmaceutical and Clinical Aspects
    Amoah, Solomon K. S.
    Sandjo, Louis P.
    Kratz, Jadel M.
    Biavatti, Maique W.
    [J]. PLANTA MEDICA, 2016, 82 (05) : 388 - 406
  • [2] Banaudha Krishna K, 2012, Methods Mol Biol, V863, P241, DOI 10.1007/978-1-61779-612-8_14
  • [3] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [4] NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype
    Bocci, Federico
    Tripathi, Satyendra C.
    Mercedes, Samuel A. Vilchez
    George, Jason T.
    Casabar, Julian P.
    Wong, Pak Kin
    Hanash, Samir M.
    Levine, Herbert
    Onuchic, Jose N.
    Jolly, Mohit Kumar
    [J]. INTEGRATIVE BIOLOGY, 2019, 11 (06) : 251 - 263
  • [5] Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways
    Cao, Lei
    Chen, Xin
    Xiao, Xue
    Ma, Qingyong
    Li, Wei
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (02) : 735 - 743
  • [6] Activation of Nrf2 Reduces UVA-Mediated MMP-1 Upregulation via MAPK/AP-1 Signaling Cascades: The Photoprotective Effects of Sulforaphane and Hispidulin
    Chaiprasongsuk, Anyamanee
    Lohakul, Jinaphat
    Soontrapa, Kitipong
    Sampattavanich, Somponnat
    Akarasereenont, Pravit
    Panich, Uraiwan
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 360 (03) : 388 - 398
  • [7] The role of Nrf2 in oxidative stress-induced endothelial injuries
    Chen, Bo
    Lu, Yanrong
    Chen, Younan
    Cheng, Jingqiu
    [J]. JOURNAL OF ENDOCRINOLOGY, 2015, 225 (03) : R83 - R99
  • [8] Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
    Filipowicz, Witold
    Bhattacharyya, Suvendra N.
    Sonenberg, Nahum
    [J]. NATURE REVIEWS GENETICS, 2008, 9 (02) : 102 - 114
  • [9] Sixty Years of CA: A Cancer Journal for Clinicians
    Gansler, Ted
    Ganz, Patricia A.
    Grant, Marcia
    Greene, Frederick L.
    Johnstone, Peter
    Mahoney, Martin
    Newman, Lisa A.
    Oh, William K.
    Thomas, Charles R., Jr.
    Thun, Michael J.
    Vickers, Andrew J.
    Wender, Richard C.
    Brawley, Otis Webb
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (06) : 345 - 350
  • [10] Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating miR-506 and suppressing MMP2/16 expression in pancreatic cancer
    Han, Yongguang
    Ma, Ligang
    Zhao, Le
    Feng, Weisheng
    Zheng, Xiaoke
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 115